Toggle Nav
Close
  • Menu
  • Setting

Anti-TNFSF11/RANKL/CD254 Antibody (Denosumab)

Catalog No.
F1550
Anti-TNFSF11/RANKL/CD254 Antibody (Denosumab)
Grouped product items
SizePriceStock Qty
100ug
Please inquire
Ship with 3-5 days
1mg
Please inquire
Ship with 3-5 days
For scientific research use only and should not be used for diagnostic or medical purposes.

Tel: +1-832-696-8203

Email: [email protected]

Worldwide Distributors

Background

Denosumab (anti-TNFSF11) is a RANKL inhibitor that is effective in inhibiting giant cell tumor of bone (GCTB). Denosumab eliminates RANK-positive tumor giant cells and reduces the relative content of proliferative, densely cellular tumor stromal cells.

Quality Control

Quality Control & DataSheet

View current batch:
 

M.Wt

145.16 kDa

Shipping

Dry ice

Cas No.

615258-40-7

Storage

-80°C

Expiration Date

2 years

Form

Liquid

Concentration

See label

Reconstitution

For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.

Host

CHO

Alternative Names

AMG-162

Buffer System

100 mM Pro 20 mM Arg pH 5.0. No preservative!

Target Accession

O14788

Reactivity

Human, Mouse, Rat

Conjugation

Unconjugated

Clonality

Monoclonal

Purification

Protein A

Isotype

IgG1

Application

ELISA, FACS, Kinetics, Functional assay, Animal Model

Target

TNFSF11 / RANKL / CD254

Note

Please avoid freeze-thaw cycles.